Patterns of Antibiotics Resistance

Patterns of Antibiotics Resistance Among Respiratory ICU Patients

Antibiotics resistance has become a global health challenge especially in third world countries. The main causes of antibiotics resistance are the improper use or overuse of antibiotics, the lack of skilled public health workers and poor hygiene standards. Resistance to antibiotics reduces the effectiveness of these treatments and has a negative impact on hospital systems especially in intensive care settings.

Medical intensive care unit (MICU) is commonly known as a "hotbed of infections" in high-risk healthcare environments ICU patients are especially prone to infections because of the various invasive procedures they undergo,including vascular access, mechanical ventilation, and intubation.

Study Overview

• Status: Not yet recruiting
• Conditions: Antibiotics Resistance
• Intervention / Treatment: Drug: Antibiotics

• Study Type: Observational
• Enrollment (Estimated): 100

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

All patients will be admitted at respiratory ICU with respiratory infection who have been treated with antibiotics and patients in whom adequate respiratory specimen

Description

Inclusion Criteria:

• All patients will be admitted at respiratory ICU with respiratory infection who have been treated with antibiotics and patients in whom adequate respiratory specimen is obtained will be included in the study

Exclusion Criteria:

• Patients who are HIV positive, who can't provide adequate respiratory specimen, patients who are not on antibiotics and patients who die within 48 hours after admission

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Patterns of Antibiotics Resistance	Number of resistance to antibiotics among ICU patients	6months to 1 year

Collaborators and Investigators

• Sponsor: Sohag University

Study record dates

Study Major Dates

• Study Start (Estimated): November 15, 2024
• Primary Completion (Estimated): October 15, 2025
• Study Completion (Estimated): October 15, 2025

Study Registration Dates

• First Submitted: November 8, 2024
• First Submitted That Met QC Criteria: November 17, 2024
• First Posted (Estimated): November 20, 2024

Study Record Updates

• Last Update Posted (Estimated): November 20, 2024
• Last Update Submitted That Met QC Criteria: November 17, 2024
• Last Verified: November 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Anti-Infective Agents; Anti-Bacterial Agents
• Other Study ID Numbers: Soh-Med-15-10_14MS

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No